The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Cystadenocarcinoma, Mucinous

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Cystadenocarcinoma, Mucinous


High impact information on Cystadenocarcinoma, Mucinous


Chemical compound and disease context of Cystadenocarcinoma, Mucinous


Biological context of Cystadenocarcinoma, Mucinous


Anatomical context of Cystadenocarcinoma, Mucinous


Gene context of Cystadenocarcinoma, Mucinous


Analytical, diagnostic and therapeutic context of Cystadenocarcinoma, Mucinous


  1. Gastroparesis after celiac plexus block. Iftikhar, S., Loftus, E.V. Am. J. Gastroenterol. (1998) [Pubmed]
  2. Presence of gonadotropin-releasing hormone and its messenger ribonucleic acid in human ovarian epithelial carcinoma. Ohno, T., Imai, A., Furui, T., Takahashi, K., Tamaya, T. Am. J. Obstet. Gynecol. (1993) [Pubmed]
  3. Human granulocyte-macrophage colony-stimulating factor is a growth factor active on human ovarian cancer cells. Cimoli, G., Russo, P., Billi, G., Mariani, G.L., Rovini, E., Venturini, M. Jpn. J. Cancer Res. (1991) [Pubmed]
  4. Expression of nerve growth factor in human pancreatic beta cells. Vidaltamayo, R., Mery, C.M., Angeles-Angeles, A., Robles-Díaz, G., Hiriart, M. Growth Factors (2003) [Pubmed]
  5. Successful pregnancy in a patient with pseudomyxoma peritonei arising from ovarian mucinous cystadenocarcinoma treated with cisplatin. Niwa, K., Morishita, S., Murase, T., Kawabata, I., Imai, A., Shimokawa, K., Tamaya, T. Gynecol. Oncol. (1995) [Pubmed]
  6. Glycosphingolipids of various human ovarian tumors: a significantly high expression of I3SO3GalCer and Lewis antigen in mucinous cystadenocarcinoma. Kiguchi, K., Takamatsu, K., Tanaka, J., Nozawa, S., Iwamori, M., Nagai, Y. Cancer Res. (1992) [Pubmed]
  7. Characterization of the carcinoembryonic antigen activity associated with cyst fluids of mucinous ovarian cystadenocarcinoma. Yamashita, K., Aitio, M.L., Dawson, J.R. Cancer Res. (1979) [Pubmed]
  8. Mucinous cystadenocarcinoma of the breast. Koenig, C., Tavassoli, F.A. Am. J. Surg. Pathol. (1998) [Pubmed]
  9. Hepatobiliary and pancreatic mucinous cystadenocarcinomas with mesenchymal stroma: analysis of estrogen receptors/progesterone receptors and expression of tumor-associated antigens. Weihing, R.R., Shintaku, I.P., Geller, S.A., Petrovic, L.M. Mod. Pathol. (1997) [Pubmed]
  10. Biochemical markers in ovarian cancer: possibilities and limitations. Haije, W.G. Ann. Clin. Biochem. (1982) [Pubmed]
  11. Complete response of a stage IV mucinous cystadenocarcinoma of the ovary to systemic chemotherapy employing paclitaxel and carboplatin. Yokoyama, Y., Kaji, H., Kondoh, H., Takeuchi, E., Yamasaki, Y., Inui, Y. Gynecol. Obstet. Invest. (2001) [Pubmed]
  12. Accumulation of technetium-99m MDP in pseudomyxoma peritonei. Kida, T., Tsuda, F., Fujita, Y., Munakata, S., Sasaki, M. Annals of nuclear medicine. (1990) [Pubmed]
  13. p53 protein expression and DNA ploidy in cystic tumors of the pancreas. Fléjou, J.F., Boulange, B., Bernades, P., Belghiti, J., Hénin, D. Pancreas (1996) [Pubmed]
  14. Cytogenetic changes in ovarian mucinous cystadenocarcinoma of low malignant potential with persistent pseudomyxoma peritonei. Vasilev, S.A., Meloni, A.M., Sandberg, A.A. Cancer Genet. Cytogenet. (1995) [Pubmed]
  15. Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells. Miyagi, E., Yasumitsu, H., Hirahara, F., Minaguchi, H., Koshikawa, N., Miyazaki, K., Umeda, M. Jpn. J. Cancer Res. (1995) [Pubmed]
  16. Expression of epidermal growth factor-related proteins and epidermal growth factor receptor in common epithelial ovarian tumors. Niikura, H., Sasano, H., Sato, S., Yajima, A. Int. J. Gynecol. Pathol. (1997) [Pubmed]
  17. Immunohistochemical detection of pregnancy-specific protein (SP1) and placenta-specific tissue proteins (PP5, PP10, PP11 and PP12) in ovarian adenocarcinomas. Inaba, N., Ishige, H., Ijichi, M., Satoh, N., Ohkawa, R., Sekiya, S., Shirotake, S., Takamizawa, H., Renk, T., Bohn, H. Oncodev. Biol. Med. (1982) [Pubmed]
  18. A study of cyst fluid and plasma carcinoembryonic antigen in patients with cystic ovarian neoplasms. van Nagell, J.R., Pletsch, Q.A., Goldenberg, D.M. Cancer Res. (1975) [Pubmed]
  19. A case of primary mucinous cystadenocarcinoma of the appendix with elevated serum carcinoembryonic antigen (CEA). Noritake, N., Ito, Y., Yamakita, N., Azuma, S., Shimokawa, K., Miura, K. Jpn. J. Med. (1990) [Pubmed]
  20. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma. Kudoh, K., Kikuchi, Y., Kita, T., Tode, T., Takano, M., Hirata, J., Mano, Y., Yamamoto, K., Nagata, I. Gynecol. Obstet. Invest. (1999) [Pubmed]
WikiGenes - Universities